<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anal fissure: Medical management
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anal fissure: Medical management
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anal fissure: Medical management
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ronald Bleday, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Martin Weiser, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lawrence S Friedman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 19, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H72480775">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anal fissure is one of the most common benign anorectal conditions. Trauma to the anoderm with the passage of a hard stool is thought to be a common initiating factor. Persistence of a fissure is typically associated with anal spasm or high anal pressure. The treatment of anal fissure breaks the cyclic anal sphincter spasm, prevents tearing of the anal mucosa, and promotes healing of the fissure.
        </p>
        <p>
         The majority of anal fissures are treated medically, which is the topic of this discussion [
         <a href="#rid1">
          1,2
         </a>
         ]. Surgical therapy, which is reserved for refractory anal fissures, is discussed in another topic. The clinical manifestations, diagnosis, and prevention of anal fissure are also discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14998.html" rel="external">
          "Anal fissure: Surgical management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2543.html" rel="external">
          "Anal fissure: Clinical manifestations, diagnosis, prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4056176745">
         <span class="h1">
          ATYPICAL FISSURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anal fissures can be primary or secondary. Most typical fissures are primary and are caused by local trauma in the context of anal spasm or high anal pressure. Primary anal fissures are most commonly located at the posterior midline and less commonly at the anterior midline. Secondary, or atypical, anal fissures are caused by another disease process such as Crohn disease and can occur at locations other than the midline. (See
         <a class="medical medical_review" href="/z/d/html/2543.html" rel="external">
          "Anal fissure: Clinical manifestations, diagnosis, prevention", section on 'Etiology'
         </a>
         .)
        </p>
        <p>
         Thus, finding of an anal fissure that is not at the midline should prompt an evaluation for Crohn disease, although Crohn-related fissures can also occur at the midline. Other manifestations of perianal Crohn disease include the presence of multiple, recurring, or nonhealing fissures; unusually deep or wide fissures; painless fissures; and perianal skin tags that are hypertrophic, edematous, and tender. Patients with suspected Crohn-related fissures should be referred to a gastroenterologist for further evaluation. (See
         <a class="medical medical_review" href="/z/d/html/4082.html" rel="external">
          "Perianal Crohn disease", section on 'Anal fissures'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H72479757">
         <span class="h1">
          INITIAL MANAGEMENT OF TYPICAL FISSURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with a typical anal fissure (ie, a single posterior or anterior fissure with no evidence of Crohn disease), we recommend prescribing a combination of supportive measures (fiber, sitz bath, topical analgesic) and one of the topical vasodilators (
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         or
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ) for one month (
         <a class="graphic graphic_algorithm graphicRef82392" href="/z/d/graphic/82392.html" rel="external">
          algorithm 1
         </a>
         ). In addition, patients who are constipated should receive a stool softener or laxative. The treatment goal is to relax the internal anal sphincter, initiate and maintain atraumatic passage of stool, and relieve pain.
        </p>
        <p>
         Although medical therapy is less effective than surgery, especially for chronic anal fissures, it should be offered first because of its wide availability, better tolerance, and lack of severe complications (ie, fecal incontinence) [
         <a href="#rid3">
          3,4
         </a>
         ]. The best data come from a trial that randomly assigned 54 patients with anal fissures to receive either a lateral internal sphincterotomy (surgery) or 0.2%
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ointment (medical therapy) for 10 weeks; all patients received warm sitz baths and a fiber-bulking agent [
         <a href="#rid5">
          5
         </a>
         ]. Compared with the medicine group, the surgery group achieved higher rates of fissure healing (96 versus 67 percent at 5 weeks and 100 versus 89 percent at 10 weeks) at the expense of a significantly higher rate of minor fecal incontinence (44 versus 0 percent). Fifteen percent of patients who underwent surgery had residual fecal incontinence after two years.
        </p>
        <p>
         The optimal duration of topical vasodilator treatment was studied in a randomized trial [
         <a href="#rid6">
          6
         </a>
         ]. There were no added benefits in treating anal fissure with 0.4% topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ointment for 80 days compared with 40 days. Fissure healing and pain improvement continue until six weeks of treatment but are unlikely thereafter.
        </p>
        <p class="headingAnchor" id="H3548714">
         <span class="h2">
          Fiber
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fiber therapy prevents hard bowel movements, which could reinjure a healing fissure.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increasing dietary fiber and water intake is the best way to soften and bulk the stool. The recommended dietary fiber intake is between 20 and 35 grams per day (
         <a class="graphic graphic_table graphicRef52349" href="/z/d/graphic/52349.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who continue to have difficulty with hard bowel movements despite increasing dietary fiber intake may use fiber supplements, such as
         <a class="drug drug_general" data-topicid="9834" href="/z/d/drug information/9834.html" rel="external">
          psyllium
         </a>
         seed (Metamucil),
         <a class="drug drug_general" data-topicid="10153" href="/z/d/drug information/10153.html" rel="external">
          methylcellulose
         </a>
         (Citrucel),
         <a class="drug drug_general" data-topicid="16098" href="/z/d/drug information/16098.html" rel="external">
          wheat dextrin
         </a>
         (Benefiber), and calcium
         <a class="drug drug_general" data-topicid="10065" href="/z/d/drug information/10065.html" rel="external">
          polycarbophil
         </a>
         (Fibercon). These over-the-counter products work by absorbing water and increasing stool bulk, which increases the frequency of bowel movements and softens stool. Fiber supplements are safe for daily use, non-habit-forming, and can be used lifelong. Possible side effects may include gas and bloating, especially when they are first started. (See
         <a class="medical medical_patient" href="/z/d/html/2003.html" rel="external">
          "Patient education: Constipation in adults (Beyond the Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3548834">
         <span class="h2">
          Sitz bath
         </span>
         <span class="headingEndMark">
          —
         </span>
         Warm sitz baths, which can relax the anal sphincter and improve blood flow to the anal mucosa, are recommended for patients with anal fissures [
         <a href="#rid7">
          7,8
         </a>
         ]. During a sitz bath, the anus is immersed in warm water for approximately 10 to 15 minutes two to three times daily. Sitz bath kits are available in most drugstores, and portable bowls can be used at work or school. At home, it is also possible to use a bathtub for sitz bath by filling it with two to three inches of warm water. Additives such as soap and bubble bath are not recommended. After a sitz bath, it is important to towel or blow dry (with a hair dryer on low heat setting) the anal area well.
        </p>
        <p class="headingAnchor" id="H3548879">
         <span class="h2">
          Topical analgesics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although topical analgesic jelly or creams (eg, 2%
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         jelly) are often prescribed for patients with an anal fissure for pain control, their use
         <strong>
          alone
         </strong>
         has not been shown to be more effective than other supportive measures [
         <a href="#rid9">
          9
         </a>
         ]. However, some prescribers add a topical analgesic to a topical vasodilator for patient comfort when the topical vasodilator is custom made by a compounding pharmacy. As an example,
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ointment can be made with or without topical lidocaine.
        </p>
        <p class="headingAnchor" id="H557732448">
         <span class="h2">
          Stool softener or laxative
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of drugs (eg,
         <a class="drug drug_general" data-topicid="9382" href="/z/d/drug information/9382.html" rel="external">
          docusate
         </a>
         ) and natural products are available for treating constipation either over the counter or by prescription. Constipation may lead to straining, which can exacerbate the anal fissure.
        </p>
        <p class="headingAnchor" id="H72479771">
         <span class="h2">
          Topical vasodilators
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aside from supportive measures, patients with anal fissures are also prescribed one of two topical vasodilators: topical
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         or topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         . We recommend using 0.2 to 0.3% nifedipine ointment two to four times daily in patients who have access to a compounding pharmacy because nifedipine ointment has fewer side effects and potential drug interactions compared with nitroglycerin. For patients who do not have access to a compounding pharmacy, we recommend using 0.4% nitroglycerin rectal ointment (Rectiv) twice daily, as it is commercially available.
        </p>
        <p class="headingAnchor" id="H3548935">
         <span class="h3">
          Topical nifedipine
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          Nifedipine
         </a>
         can be compounded into a gel form and applied on or around the fissure in the anal canal to reduce the anal sphincter pressure. Topical nifedipine is typically used two to four times daily as a 0.2 to 0.3% ointment.
        </p>
        <p>
         In a trial of 52 patients with chronic anal fissures, treatment with topical
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         resulted in more healing (89 versus 58 percent) and fewer side effects (5 versus 40 percent) compared with topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         [
         <a href="#rid10">
          10
         </a>
         ]. Recurrence rates at 124 to 183 weeks were comparable between the two groups (42 versus 31 percent).
        </p>
        <p class="headingAnchor" id="H72479779">
         <span class="h3">
          Topical nitroglycerin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         promotes the healing of anal fissure by increasing local blood flow and reducing pressure in the internal anal sphincter. The observation that the posterior commissure of the internal sphincter is less perfused than the other sections led to the concept that ischemia could be contributing to the persistence of anal fissures [
         <a href="#rid11">
          11,12
         </a>
         ].
        </p>
        <p>
         Topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         is typically applied rectally as a 0.2 or 0.4% ointment twice daily for eight weeks. A 0.4% nitroglycerin ointment (Rectiv) is commercially available. Alternatively, a lower dose of 0.2% nitroglycerin ointment can be custom made by a pharmacist.
        </p>
        <p>
         Topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         is an effective treatment for anal fissures [
         <a href="#rid13">
          13-20
         </a>
         ]. A meta-analysis found topical nitroglycerin to be superior to placebo in healing anal fissures (49 versus 36 percent), but 50 percent of patients successfully treated with topical nitroglycerin developed recurrent fissures [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The major side effects of topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         are headaches and hypotension. Headaches generally occur 10 to 15 minutes after application and last no more than 30 minutes in most patients [
         <a href="#rid21">
          21
         </a>
         ]. Headaches occur most commonly during the initial two weeks of therapy and decrease thereafter.
        </p>
        <p>
         Hypotension can cause dizziness. Thus, patients should sit or lie down when applying the ointment and should stand up slowly afterwards. To avoid serious drug interactions, topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         should not be used within 24 hours of taking medications for erectile dysfunction, such as
         <a class="drug drug_general" data-topicid="9643" href="/z/d/drug information/9643.html" rel="external">
          sildenafil
         </a>
         (Viagra),
         <a class="drug drug_general" data-topicid="10108" href="/z/d/drug information/10108.html" rel="external">
          tadalafil
         </a>
         (Cialis), or
         <a class="drug drug_general" data-topicid="10172" href="/z/d/drug information/10172.html" rel="external">
          vardenafil
         </a>
         (Levitra). (See
         <a class="medical medical_review" href="/z/d/html/7469.html" rel="external">
          "Treatment of male sexual dysfunction"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/1993.html" rel="external">
          "Patient education: Anal fissure (Beyond the Basics)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H895006069">
         <span class="h2">
          Tocopherol
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a randomized trial of 160 patients with chronic anal fissure, a greater proportion of patients were relieved of all anal pain at two weeks (74 versus 61 percent, p = 0.09) and eight weeks (88 versus 74 percent, p = 0.007) after treatment with tocopherol acetate (vitamin E) ointment than with glyceryl trinitrate ointment [
         <a href="#rid22">
          22
         </a>
         ]. At 16 weeks after completion of treatment, patients treated with tocopherol acetate ointment had fewer recurrences than those treated with glyceryl trinitrate ointment (3 versus 13 percent). If these results can be replicated by other studies, tocopherol may become an alternative treatment for anal fissure to topical vasodilators that has fewer side effects.
        </p>
        <p class="headingAnchor" id="H21460728">
         <span class="h1">
          INTERVAL EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         After one month of initial treatment with supportive measures and a topical vasodilator, patients are reevaluated, and those with persistent symptoms are prescribed another month of the same medical therapy (
         <a class="graphic graphic_algorithm graphicRef82392" href="/z/d/graphic/82392.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
         At the end of two months, patients who still have persistent symptoms attributable to their anal fissures are referred for endoscopy to rule out occult Crohn disease. (See
         <a class="medical medical_review" href="/z/d/html/4069.html" rel="external">
          "Overview of the medical management of mild (low risk) Crohn disease in adults", section on 'Perianal disease'
         </a>
         .)
        </p>
        <p>
         If patients are diagnosed with Crohn disease by endoscopy, they are referred to a gastroenterologist for further care. If patients are not diagnosed with Crohn disease, they are referred to a colorectal surgeon for further treatment of the refractory anal fissure. (See
         <a class="local">
          'Subsequent management of typical fissures'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3548554">
         <span class="h1">
          SUBSEQUENT MANAGEMENT OF TYPICAL FISSURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For anal fissure patients who fail medical treatment, we suggest performing either a botulinum toxin A injection or a lateral sphincterotomy. (See
         <a class="medical medical_review" href="/z/d/html/14998.html" rel="external">
          "Anal fissure: Surgical management"
         </a>
         .)
        </p>
        <p>
         For patients who are not willing or not a candidate to undergo invasive procedures, we suggest continued medical treatment of their fissure disease with the alternate topical vasodilator (
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ointment if they were treated with
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ointment, or nifedipine ointment if they were treated with nitroglycerin ointment) or one of the second-line agents (
         <a class="graphic graphic_algorithm graphicRef82392" href="/z/d/graphic/82392.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Topical vasodilators'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H21460790">
         <span class="h2">
          Second-line medical therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although surgical treatment of anal fissures is generally more effective, some patients may choose not to undergo invasive procedures because of their fear of fecal incontinence, or they may not be a suitable candidate for surgery because of comorbid conditions.
        </p>
        <p>
         Second-line medications are typically prescribed for six to eight weeks, although most patients stop taking the medication when they feel better. We generally recommend that the patient finish at least a four-week course of any treatment.
        </p>
        <p>
         Healing rates with second-line medications for anal fissures range from 38 to 75 percent (typically around 60 percent) [
         <a href="#rid23">
          23-27
         </a>
         ]. Side effects vary depending upon the medication. The usual dose, interval, and duration of these medications are listed below.
        </p>
        <p class="headingAnchor" id="H3549165">
         <span class="h3">
          Topical diltiazem
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">
          Diltiazem
         </a>
         2% rectal gel is applied three times daily for eight weeks. No significant side effects have been reported [
         <a href="#rid23">
          23-25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H72479793">
         <span class="h3">
          Topical bethanechol
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9153" href="/z/d/drug information/9153.html" rel="external">
          Bethanechol
         </a>
         0.1% rectal gel is applied three times daily for eight weeks. No significant side effects have been reported [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3549278">
         <span class="h3">
          Oral nifedipine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         , 20 mg twice daily, is typically given in an extended-release form for eight weeks in most studies [
         <a href="#rid26">
          26,28,29
         </a>
         ]. Side effects include flushing, headaches, and ankle edema. However, a 20 mg extended-release preparation of nifedipine is not available in the United States. An immediate-release form of 20 mg nifedipine is available but may cause unpredictable hypotension in some patients. The alternative is to use topical nifedipine or oral
         <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">
          diltiazem
         </a>
         .
        </p>
        <p class="headingAnchor" id="H3549312">
         <span class="h3">
          Oral diltiazem
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral
         <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">
          diltiazem
         </a>
         , 60 mg twice daily, is given for eight weeks. Side effects include headaches, nausea, rash, and reduced smell and taste [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H935612">
         <span class="h2">
          Invasive procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         The treatment of anal fissures with invasive procedures is discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/14998.html" rel="external">
          "Anal fissure: Surgical management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2038537762">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118236.html" rel="external">
          "Society guideline links: Anal fissure"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H72479912">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/82909.html" rel="external">
          "Patient education: Anal fissure (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/1993.html" rel="external">
          "Patient education: Anal fissure (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H72481570">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Anal fissure that results from a high anal pressure is one of the most common benign anorectal conditions. The treatment of anal fissure breaks the cyclic anal sphincter spasm, prevents tearing of the anal mucosa, and promotes healing of the fissure. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atypical anal fissures
         </strong>
         – Patients with atypical anal fissures (fissures that are multiple, recurring, nonhealing, unusually deep or wide, painless, or at off-midline locations) or perianal findings suspicious for Crohn disease should be referred to a gastroenterologist. Crohn-related fissures are treated differently from typical anal fissures. (See
         <a class="local">
          'Atypical fissures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Typical anal fissures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Initial treatment
         </strong>
         – For patients with a typical anal fissure (ie, a single posterior or anterior fissure without evidence of Crohn disease), we recommend initial therapy with a combination of supportive measures (fiber, stool softener, sitz bath, topical analgesic) and one of the topical vasodilators (
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         or
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ) for one month, rather than surgery (
         <a class="graphic graphic_algorithm graphicRef82392" href="/z/d/graphic/82392.html" rel="external">
          algorithm 1
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). (See
         <a class="local">
          'Initial management of typical fissures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For patients who have access to a compounding pharmacy, we suggest
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ointment rather than
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ointment as the topical vasodilator (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). Nifedipine ointment has fewer side effects and potential drug interactions compared with nitroglycerin and may be more effective. For patients who do not have access to a compounding pharmacy, we use 0.4% nitroglycerin rectal ointment (Rectiv), which is commercially available. (See
         <a class="local">
          'Topical vasodilators'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Interval evaluation
         </strong>
         – After the initial treatment with supportive measures and one of the topical vasodilators for one month, patients are reevaluated, and those with persistent symptoms are prescribed another month of the same medical therapy. At the end of two months, patients who still have persistent symptoms attributable to their anal fissures are referred for endoscopy to rule out occult Crohn disease. Patients diagnosed with Crohn disease by endoscopy are referred to a gastroenterologist for further care. If not diagnosed with Crohn disease, the patient is referred to a colorectal surgeon for further treatment of the refractory anal fissure. (See
         <a class="local">
          'Interval evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Subsequent management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For typical anal fissure patients who fail eight weeks of initial medical treatment, we suggest botulinum toxin type A injection or a lateral internal sphincterotomy, rather than continued medical therapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/14998.html" rel="external">
          "Anal fissure: Surgical management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Patients who are not willing or not a candidate to undergo invasive procedures are treated with the alternate topical vasodilator (
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ointment if they were treated with
         <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">
          nifedipine
         </a>
         ointment, or nifedipine ointment if they were treated with nitroglycerin ointment) or one of the second-line agents (topical
         <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">
          diltiazem
         </a>
         , topical
         <a class="drug drug_general" data-topicid="9153" href="/z/d/drug information/9153.html" rel="external">
          bethanechol
         </a>
         , oral nifedipine, or oral diltiazem). (See
         <a class="local">
          'Second-line medical therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3279969071">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge Elizabeth Breen, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Shub HA, Salvati EP, Rubin RJ. Conservative treatment of anal fissure: an unselected, retrospective and continuous study. Dis Colon Rectum 1978; 21:582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen SL. Maintenance therapy with unprocessed bran in the prevention of acute anal fissure recurrence. J R Soc Med 1987; 80:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson RL, Chattopadhyay A, Brooks W, et al. Operative procedures for fissure in ano. Cochrane Database Syst Rev 2011; :CD002199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev 2012; :CD003431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parellada C. Randomized, prospective trial comparing 0.2 percent isosorbide dinitrate ointment with sphincterotomy in treatment of chronic anal fissure: a two-year follow-up. Dis Colon Rectum 2004; 47:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagliardi G, Pascariello A, Altomare DF, et al. Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective randomized multicenter trial. Tech Coloproctol 2010; 14:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Gastroenterological Association. American Gastroenterological Association medical position statement: Diagnosis and care of patients with anal fissure. Gastroenterology 2003; 124:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodi G, Bogoni F, Infantino A, et al. Hot or cold in anal pain? A study of the changes in internal anal sphincter pressure profiles. Dis Colon Rectum 1986; 29:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen SL. Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran. Br Med J (Clin Res Ed) 1986; 292:1167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ezri T, Susmallian S. Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum 2003; 46:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schouten WR, Briel JW, Auwerda JJ. Relationship between anal pressure and anodermal blood flow. The vascular pathogenesis of anal fissures. Dis Colon Rectum 1994; 37:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klosterhalfen B, Vogel P, Rixen H, Mittermayer C. Topography of the inferior rectal artery: a possible cause of chronic, primary anal fissure. Dis Colon Rectum 1989; 32:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorfine SR. Topical nitroglycerin therapy for anal fissures and ulcers. N Engl J Med 1995; 333:1156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997; 349:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oettlé GJ. Glyceryl trinitrate vs. sphincterotomy for treatment of chronic fissure-in-ano: a randomized, controlled trial. Dis Colon Rectum 1997; 40:1318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacher H, Mischinger HJ, Werkgartner G, et al. Local nitroglycerin for treatment of anal fissures: an alternative to lateral sphincterotomy? Dis Colon Rectum 1997; 40:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altomare DF, Rinaldi M, Milito G, et al. Glyceryl trinitrate for chronic anal fissure--healing or headache? Results of a multicenter, randomized, placebo-controled, double-blind trial. Dis Colon Rectum 2000; 43:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richard CS, Gregoire R, Plewes EA, et al. Internal sphincterotomy is superior to topical nitroglycerin in the treatment of chronic anal fissure: results of a randomized, controlled trial by the Canadian Colorectal Surgical Trials Group. Dis Colon Rectum 2000; 43:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuberi BF, Rajput MR, Abro H, Shaikh SA. A randomized trial of glyceryl trinitrate ointment and nitroglycerin patch in healing of anal fissures. Int J Colorectal Dis 2000; 15:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kennedy ML, Sowter S, Nguyen H, Lubowski DZ. Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and long-term follow-up. Dis Colon Rectum 1999; 42:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lund JN, Scholefield JH. Glyceryl trinitrate ointment for chronic anal fissure (letter). Lancet 1997; 349:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruiz-Tovar J, Llavero C. Perianal Application of Glyceryl Trinitrate Ointment Versus Tocopherol Acetate Ointment in the Treatment of Chronic Anal Fissure: A Randomized Clinical Trial. Dis Colon Rectum 2022; 65:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carapeti EA, Kamm MA, Phillips RK. Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000; 43:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 2001; 88:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jonas M, Speake W, Scholefield JH. Diltiazem heals glyceryl trinitrate-resistant chronic anal fissures: a prospective study. Dis Colon Rectum 2002; 45:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cook TA, Humphreys MM, McC Mortensen NJ. Oral nifedipine reduces resting anal pressure and heals chronic anal fissure. Br J Surg 1999; 86:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum 2001; 44:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agrawal V, Kaushal G, Gupta R. Randomized controlled pilot trial of nifedipine as oral therapy vs. topical application in the treatment of fissure-in-ano. Am J Surg 2013; 206:748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sahebally SM, Ahmed K, Cerneveciute R, et al. Oral versus topical calcium channel blockers for chronic anal fissure-a systematic review and meta-analysis of randomized controlled trials. Int J Surg 2017; 44:87.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 83135 Version 22.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/738173" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Conservative treatment of anal fissure: an unselected, retrospective and continuous study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3039130" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Maintenance therapy with unprocessed bran in the prevention of acute anal fissure recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22071803" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Operative procedures for fissure in ano.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22336789" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Non surgical therapy for anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14994114" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Randomized, prospective trial comparing 0.2 percent isosorbide dinitrate ointment with sphincterotomy in treatment of chronic anal fissure: a two-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20632059" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective randomized multicenter trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12512045" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : American Gastroenterological Association medical position statement: Diagnosis and care of patients with anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3948615" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Hot or cold in anal pain? A study of the changes in internal anal sphincter pressure profiles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3011180" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12794583" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8026232" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Relationship between anal pressure and anodermal blood flow. The vascular pathogenesis of anal fissures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2910660" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Topography of the inferior rectal artery: a possible cause of chronic, primary anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7565967" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Topical nitroglycerin therapy for anal fissures and ulcers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8988115" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9369106" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Glyceryl trinitrate vs. sphincterotomy for treatment of chronic fissure-in-ano: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9221864" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Local nitroglycerin for treatment of anal fissures: an alternative to lateral sphincterotomy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10696890" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Glyceryl trinitrate for chronic anal fissure--healing or headache? Results of a multicenter, randomized, placebo-controled, double-blind trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10950002" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Internal sphincterotomy is superior to topical nitroglycerin in the treatment of chronic anal fissure: results of a randomized, controlled trial by the Canadian Colorectal Surgical Trials Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11008725" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : A randomized trial of glyceryl trinitrate ointment and nitroglycerin patch in healing of anal fissures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10458121" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Glyceryl trinitrate ointment for chronic anal fissure (letter)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34803148" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Perianal Application of Glyceryl Trinitrate Ointment Versus Tocopherol Acetate Ointment in the Treatment of Chronic Anal Fissure: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11052511" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11298624" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Topical diltiazem ointment in the treatment of chronic anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12195195" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Diltiazem heals glyceryl trinitrate-resistant chronic anal fissures: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10540130" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Oral nifedipine reduces resting anal pressure and heals chronic anal fissure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11535842" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : A randomized trial of oral vs. topical diltiazem for chronic anal fissures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24035211" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Randomized controlled pilot trial of nifedipine as oral therapy vs. topical application in the treatment of fissure-in-ano.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28629764" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Oral versus topical calcium channel blockers for chronic anal fissure-a systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
